Street Smarts: Catching up with former Patagonia CEO; Pashion Footwear enters the Shark Tank
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Our View: Even tougher times ahead for local journalism
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Our View: Let Ventura County set a statewide example for farmworker outreach
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Opinion: Helping Black business owners rise to the challenge
By Redonna Carpenter-Woods 2020 was a challenging year for all. While small businesses nationwide faced unique obstacles brought on by the coronavirus, Black small business owners in particular have been disproportionally impacted by the pandemic, with one recent study by an economist at UC Santa Cruz showing that half may not survive. Despite these challenges, Read More →
Read More →Opinion: Parkinson’s diagnosis holds lessons for coping with COVID-19
By Paul D. Witman I was recently diagnosed with Parkinson’s disease, a progressive, slow-moving disease that has no known cure. My father passed away 10 years ago from the same disease, so this diagnosis generated some deep thinking about how I would respond to it. Modern science has identified treatments for many of the symptoms, Read More →
Read More →MannKind stock dips on report of 2020 losses, but company touts fourth quarter comeback
MannKind Corp. struggled during 2020, but impressive financial results from its final quarter could be a sign of good things to come for the Westlake Village biotech company. MannKind, which develops drugs and treatments for those suffering from diabetes and pulmonary arterial hypertension, reported a net loss of $57.2 million in fiscal year 2020, up Read More →
Read More →Inogen announces net loss, predicts better 2021
Goleta-based Inogen reported declines in both revenue and net income due to the COVID-19 pandemic on Feb. 24, when the maker of portable oxygen concentrators released its financial results for the fourth quarter and full year of 2020. Total revenue for the fourth quarter was $74 million, a decline of 6.3% from the same quarter Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
